ConductScience.org, home

Paper39167199

Moyamoya syndrome after proton beam therapy in a pediatric patient with a pineal germ cell tumor and a germline polymorphism in RNF213.

Lin TC and 5 others. Childs Nerv Syst, 2024. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Moyamoya syndrome after proton beam therapy in a pediatric patient with a pineal germ cell tumor and a germline polymorphism in RNF213. Papers, record 39167199. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39167199

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Moyamoya syndrome after proton beam therapy in a pediatric patient with a pineal germ cell tumor and a germline polymorphism in RNF213.
PubMed
Journal
Childs Nerv Syst
PubMed
Year
2024
PubMed
Publication types
Case Reports, Journal Article
PubMed
Citations, by iCite
1
iCite
Relative citation ratio, by iCite
0.37, provisional
iCite
Revised in PubMed
2026-11-01
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lin TCTing-Chun
2Uchino HHaruto
3Ito MMasaki
4Yamaguchi SShigeru
5Ishi YYukitomo
6Fujimura MMiki

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Moyamoya DiseaseMajor topic
Ubiquitin-Protein LigasesMajor topic
Proton TherapyMajor topic
Adenosine TriphosphatasesMajor topic
Humans
Male
Child
Neoplasms, Germ Cell and Embryonal
Pinealoma
Brain Neoplasms
Germ-Line Mutation
Polymorphism, Genetic
Pineal Gland

Source PubMed

Download CSV of topics

References29

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127038981Is Quasi-moyamoya Disease a Uniform Disease Entity? A Three-Dimensional Constructive Interference in Steady State Imaging Study.J Stroke Cerebrovasc Dis2016https://conductscience.org/library/papers/27038981PubMed
27839383Progressive cerebral occlusive disease after radiation therapy.Stroke1995https://conductscience.org/library/papers/7839383PubMed
323850618Downregulation of Securin by the variant RNF213 R4810K (rs112735431, G>A) reduces angiogenic activity of induced pluripotent stem cell-derived vascular endothelial cells from moyamoya patients.Biochem Biophys Res Commun2013https://conductscience.org/library/papers/23850618PubMed
429730064Risk of Radiation Vasculopathy and Stroke in Pediatric Patients Treated With Proton Therapy for Brain and Skull Base Tumors.Int J Radiat Oncol Biol Phys2018https://conductscience.org/library/papers/29730064PubMed
530157848Circulating miRNome profiling in Moyamoya disease-discordant monozygotic twins and endothelial microRNA expression analysis using iPS cell line.BMC Med Genomics2018https://conductscience.org/library/papers/30157848PubMed
627193755Radiation-Induced Moyamoya Syndrome after Proton Beam Therapy in the Pediatric Patient: A Case Series.Pediatr Neurosurg2016https://conductscience.org/library/papers/27193755PubMed
726126547Biochemical and Functional Characterization of RNF213 (Mysterin) R4810K, a Susceptibility Mutation of Moyamoya Disease, in Angiogenesis In Vitro and In Vivo.J Am Heart Assoc2015https://conductscience.org/library/papers/26126547PubMed
821048783A genome-wide association study identifies RNF213 as the first Moyamoya disease gene.J Hum Genet2011https://conductscience.org/library/papers/21048783PubMed
921799892Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development.PLoS One2011https://conductscience.org/library/papers/21799892PubMed
1029657988Outcomes for pediatric patients with central nervous system germ cell tumors treated with proton therapy.Clin Transl Radiat Oncol2016https://conductscience.org/library/papers/29657988PubMed
1136738468Neurosurgical management of proton beam therapy-induced moyamoya syndrome.J Neurosurg Pediatr2023https://conductscience.org/library/papers/36738468PubMed
1227744643Proton therapy in paediatric oncology: an Irish perspective.Ir J Med Sci2017https://conductscience.org/library/papers/27744643PubMed
13351974022021 Japanese Guidelines for the Management of Moyamoya Disease: Guidelines from the Research Committee on Moyamoya Disease and Japan Stroke Society.Neurol Med Chir (Tokyo)2022https://conductscience.org/library/papers/35197402PubMed
1418940695Moyamoya disease: current concepts and future perspectives.Lancet Neurol2008https://conductscience.org/library/papers/18940695PubMed
1522688070Lessons learned from moyamoya disease: outcome of direct/indirect revascularization surgery for 150 affected hemispheres.Neurol Med Chir (Tokyo)2012https://conductscience.org/library/papers/22688070PubMed
1633664967Systematic review of the incidence and risk factors for cerebral vasculopathy and stroke after cranial proton and photon radiation for childhood brain tumors.Neurooncol Pract2021https://conductscience.org/library/papers/33664967PubMed
1735613882Diagnostic Criteria for Moyamoya Disease - 2021 Revised Version.Neurol Med Chir (Tokyo)2022https://conductscience.org/library/papers/35613882PubMed
1832387488Pencil beam scanning proton therapy for the treatment of craniopharyngioma complicated with radiation-induced cerebral vasculopathies: A dosimetric and linear energy transfer (LET) evaluation.Radiother Oncol2020https://conductscience.org/library/papers/32387488PubMed
198890997Occlusion of the anterior cerebral artery after Gamma Knife irradiation in a rat.Acta Neurochir (Wien)1996https://conductscience.org/library/papers/8890997PubMed
2027662211Cellular Functions and Gene and Protein Expression Profiles in Endothelial Cells Derived from Moyamoya Disease-Specific iPS Cells.PLoS One2016https://conductscience.org/library/papers/27662211PubMed

See all 29 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
40869185Multisystemic Impact of RNF213 Arg4810Lys: A Comprehensive Review of Moyamoya Disease and Associated Vasculopathies.Int J Mol Sci2025https://conductscience.org/library/papers/40869185

Source PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
RNF21357674PubTator's text mininghttps://conductscience.org/library/genes/57674

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39167199

GET https://conductscience.org/api/papers/v1/39167199/references?page=2